Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on: March 30,2024

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on:March 30,2024

Causes and Risk Factors of Non-Small Cell Lung Cancer

Causes and Risk Factors of Non-Small Cell Lung CancerByLynne Eldridge, MDUpdated on July 16, 2021Medically reviewed byDoru Paul, MDWhile the exact causes ofnon-small cell

Updated on: January 28,2024

Causes and Risk Factors of Non-Small Cell Lung Cancer

Causes and Risk Factors of Non-Small Cell Lung CancerByLynne Eldridge, MDUpdated on July 16, 2021Medically reviewed byDoru Paul, MDWhile the exact causes ofnon-small cell

Updated on:January 28,2024

Model illuminates environmental cues that may contribute to breast cancer recurrence

by Karen B. Roberts,University of DelawareUniversity of Delaware post-doctoral researcher Lina Pradham loads a protocol and plate into a bioprinter made by Inventia. Called the RASTRUM, the Inve

Updated on: December 22,2023

Model illuminates environmental cues that may contribute to breast cancer recurrence

by Karen B. Roberts,University of DelawareUniversity of Delaware post-doctoral researcher Lina Pradham loads a protocol and plate into a bioprinter made by Inventia. Called the RASTRUM, the Inve

Updated on:December 22,2023

Breast cancer patients with government insurance at higher risk of death

by ECOG-ACRIN Cancer Research GroupSamilia Obeng-Gyasi, MD (The Ohio State University) is the lead author on an analysis of the insurance status of 9800 breast cancer patients and their clinical outco

Updated on: December 22,2023

Breast cancer patients with government insurance at higher risk of death

by ECOG-ACRIN Cancer Research GroupSamilia Obeng-Gyasi, MD (The Ohio State University) is the lead author on an analysis of the insurance status of 9800 breast cancer patients and their clinical outco

Updated on:December 22,2023

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant

Updated on: December 26,2023

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant

Updated on:December 26,2023

Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainImplementing lung cancer screening at four diverse healthcare systems resulted in an 8.4 percent increase in t

Updated on: December 22,2023

Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainImplementing lung cancer screening at four diverse healthcare systems resulted in an 8.4 percent increase in t

Updated on:December 22,2023

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde

Updated on: December 20,2023

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde

Updated on:December 20,2023

Study offers a potential strategy to improve T cell therapy in solid tumors

byPerelman School of Medicine at the University of PennsylvaniaRegnase-1 and Roquin-1 double knockout alters the activation profile of resting engineered T cells. (A) Healthy human donor T cells

Updated on: December 22,2023

Study offers a potential strategy to improve T cell therapy in solid tumors

byPerelman School of Medicine at the University of PennsylvaniaRegnase-1 and Roquin-1 double knockout alters the activation profile of resting engineered T cells. (A) Healthy human donor T cells

Updated on:December 22,2023

Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma

by United European GastroenterologyCredit: Unsplash/CC0 Public DomainEating a Mediterranean diet rich in fiber, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunoth

Updated on: December 20,2023

Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma

by United European GastroenterologyCredit: Unsplash/CC0 Public DomainEating a Mediterranean diet rich in fiber, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunoth

Updated on:December 20,2023

Scientists discover mucus allows young pancreatic cancer cells to grow but may also prevent a deadly transformation

FEBRUARY 28, 2024by Luis Sandoval,Cold Spring Harbor LaboratoryA cross-section of a mouse's early-stage pancreatic tumor. CSHL scientists discovered that early pancreatic cancer cells depend

Updated on: March 15,2024

Scientists discover mucus allows young pancreatic cancer cells to grow but may also prevent a deadly transformation

FEBRUARY 28, 2024by Luis Sandoval,Cold Spring Harbor LaboratoryA cross-section of a mouse's early-stage pancreatic tumor. CSHL scientists discovered that early pancreatic cancer cells depend

Updated on:March 15,2024

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on: December 18,2023

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on:December 18,2023

Cancer screening and detection remain below prepandemic levels

At the end of 2021, population-based screening and diagnosis remained below prepandemic levels for breast, cervical, and colorectal cancers, according to a research letter published online Nov. 17 in&

Updated on: December 18,2023

Cancer screening and detection remain below prepandemic levels

At the end of 2021, population-based screening and diagnosis remained below prepandemic levels for breast, cervical, and colorectal cancers, according to a research letter published online Nov. 17 in&

Updated on:December 18,2023